Multihance

Active Ingredient(s): Gadobenate Dimeglumine
FDA Approved: * November 23, 2004
Pharm Company: * BRACCO
Category: Diagnostic Aid

Gadobenic acid (INN, brand name Multihance) is a complex of gadolinium with the ligand BOPTA. In the form of the methylglucamine salt meglumine gadobenate (INNm) or gadobenate dimeglumine (USAN), it is used as a gadolinium-based MRI contrast medium.[3] BOPTA is a derivative of DTPA in which one terminal carboxyl group, –C(O)OH is replaced by -C–O–CH2C6H5. Thus gadobenic acid is closely related to gadopentetic acid. BOPTA itself was first synthesized in 1995.&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Multihance 529 mg/ml Intravenous Injection, Solution
NDC: 0270-5164
Labeler:
Bracco Diagnostics Inc
Multihance 529 mg/ml Intravenous Injection, Solution
NDC: 0270-5264
Labeler:
Bracco Diagnostics Inc

Related Brands

Drugs with the same active ingredients